Flow cytometric analysis of Human Peripheral Blood cells labelling Human CD95 antibody at 1/200 dilution (1 μg) / (Red) compared with Mouse IgG1, κ Isotype Control (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti - Mouse IgG Alexa Fluor® 488 was used as the secondary antibody.
Product Details
Product Details
Product Specification
Host | Mouse |
Antigen | CD95 |
Synonyms | Tumor necrosis factor receptor superfamily member 6; Apo-1 antigen; Apoptosis-mediating surface antigen FAS; FASLG receptor; APT1; FAS1; TNFRSF6; FAS |
Location | Cell membrane |
Accession | P25445 |
Clone Number | S-3025 |
Antibody Type | Mouse mAb |
Isotype | IgG1,k |
Application | FCM |
Reactivity | Hu |
Positive Sample | Human Peripheral Blood cells |
Purification | Protein G |
Concentration | 2 mg/ml |
Conjugation | Unconjugated |
Physical Appearance | Liquid |
Storage Buffer | PBS pH7.4 |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
application | dilution | species |
FCM | 1:200 | Hu |
Background
CD95, also known as Fas or APO-1, is a protein that plays a crucial role in the regulation of apoptosis, or programmed cell death. It is a member of the tumor necrosis factor receptor superfamily and is expressed on the surface of various immune cells, including T cells and B cells. When CD95 is engaged by its ligand, CD95L, it triggers a signaling cascade involving the recruitment of adaptor proteins such as FADD, which in turn activates caspases, leading to the dismantling of the cell. This pathway is essential for maintaining immune homeostasis by eliminating activated or damaged cells. Dysregulation of CD95 signaling has been implicated in a range of diseases, including autoimmune disorders and cancer, highlighting its importance in both physiological and pathological contexts.
Picture
Picture
FC
